O ne of the major strategies employed in cancer chemotherapy 1, 2 is the use of small molecules that disrupt DNA replication and so halt rapid cellular division and promote cell apoptosis. To this end, molecules that intercalate double-stranded DNA have shown promise as anticancer agents often as a result of the inhibition of topoisomerase enzymes.
3À5
Intercalating compounds include ethidium bromide, 6À11 proflavine 11À16 and doxorubicin, 3 ,17À22 the last of which has been approved clinically and is administered as the hydrochloride salt in the clinic to treat a variety of cancers. Although effective as a chemotherapeutic agent, prolonged therapeutic regiments using doxorubicin lead to serious adverse implications 17, 22 for the cardiovascular system, the most significant 17 of which is cardiomyopathy. Continuing efforts, therefore, to uncover alternative drug candidates for anticancer treatments to improve upon established therapeutics remains a top priority in the eyes of medicinal chemists. From these continuing efforts, other DNA-intercalating drug candidates, such as Mitonafide 23, 24 and Amodafide 25, 26 and the bisintercalating Elinafide, 27À30 have been identified 31À33 and shown to be highly cytotoxic to cancer cells. After numerous clinical studies 29 of these candidates, however, many compounds have yet to be developed as chemotherapeutic agents on account of their doselimiting toxicity. In order to develop new drugs that follow the established DNA-intercalation pathway, and yet have different pharmacokinetics, we need to find out more about the physical properties of the drug candidates. The most common structural feature of these DNA intercalators is the presence of a planar aromatic region to aid and abet stacking in between the DNA bases. Although there are many examples of anticancer drug candidates, such as naphthalene diimide-based compounds, 33 containing extended aromatic regions, their low solubilities in aqueous solutions have often limited anticancer therapeutic-based applications. Molecules which contain an aromatic region, while remaining water-soluble, are particularly promising drug candidates. These two properties are especially true for cationic DNA intercalators, since investigations 34, 35 have shown that electrostatic interactions with the negatively charged phosphate backbone of DNA can leverage attractive Coulombic intercalation interactions. Recently, we have been investigating 36À39 the materials properties of the N,N 0 -dimethyl-2,9-diazaperopyrenium dication (dimethyl-DAPP 2þ ), which has ( Figure 1 ) an extended, electron-rich aromatic core region flanked on either side by electron-deficient pyridinium rings. This compound has found use in mechanically interlocked molecules 36 45 that treatment of these cell lines with 4,9-diazapyrenium derivatives, in concentrations ranging from 100 nM to 100 μM, resulted in growth inhibition in excess of 50%, as well as their being more specific against the cancer cell lines than the WI-38 cell line. Additionally, the 2,7-diazapyrenium dication has been demonstrated 46 to undergo photochemical clevage of both supercoiled DNA pBR322 and DNA M13mp19. Given the anticancer activity of the diazapyrenium dications, we might expect that the DAPP 2þ dications would also possess anticancer activity, and may be more effective intercalators than the diazapyrenium dications on account of their extended polyaromatic cores. In our research on these dications, we sought to test the anticancer activity of a library of compounds. Since small structural variations may result in substantial differences in therapeutic activity and, given the fact that the dimethyl-DAPP 2þ dication is capable of homophilic recognition, we synthesized a small library of compounds which can influence directly the way in which the dications interact with each other in solution. A cell proliferation assay was run in order to test the activity of each member of the library and we discovered that one candidate in particular has promising efficacy. Additionally, we have tested the efficacy of DAPP 2þ -related compounds with different levels of aromaticity and found that there is a considerable difference between the potency of the completely aromatic diazaperopyrenium dications and the ARTICLE hexahydroanthradiisoquinoline dications, which have less aromaticity, with the same functional groups on the 2 and 9 positions. the dications pack in such a way as to form onedimensional stacks. In this geometry, the perylene core of one dication is available to take part in π 3 3 3 π interactions with the perylene core of two neighboring dications which stack in a repetitive ABC manner so that the angle of NÀN vectors between adjacent dications is approximately 60°, presumably to minimize Coulombic repulsions while maximizing π 3 3 3 π overlaps. Dication ARTICLE groups are nearly perpendicular (82°) to the DAPP 2þ plane and result in the dications packing in a herringbone-like fashion. The presence of the two 2,6-iPr 2 C 6 H 3 groups also increases the solubility of the DAPP 2þ dication in aqueous and polar organic solvents using chloride or hexafluorophosphate anions, respectively, compared to other groups, e.g., as in the p-MeC 6 H 4 and m-MeC 6 H 4 derivatives, on account of the restricted ability of these dications to aggregate, a phenomenon which is also observed 47À52 with the related perylene diimides in organic solvents. Given the facts (i) that DNA intercalators are common targets 58 The dichloride 8 3 2Cl exhibited significant potency with less than 50% cell viability, against all but two of the cell lines tested, with the SKMEL-2 cell line having the lowest cell viability (7.2 ( 2.5%) when exposed to 10 μM of 8 3 2Cl. The data in Table 1 and the histogram illustrated in Figure 5a reveal six cell lines in which 8 3 2Cl had close to the same, or greater, potency as doxorubicin. These encouraging results prompted us to (i) investigate the anticancer activity of 8 3 2Cl further by performing a proliferation assay at various concentrations of the salt and (ii) generate We hypothesize that it is the propensity of the DAPP 2þ salts to self-aggregate and the availability of the perylene core to take part in π 3 3 3 π or hydrophobic interactions which affects the potency of the compounds as cancer therapeutic agents when testing a library of these compounds. We recall that the packing in the solid state of the DAPP 2þ dications 1 2þ through 7 2þ all show that π 3 3 3 π stacking interactions play a significant role in driving molecular orientation in their crystalline states. It is also reasonable to conclude that a hydrophobic effect operates in aqueous solution. When these π 3 3 3 π intermolecular interactions are inhibited by steric shielding of the diazaperopyrenium cores, the solution-phase molecules more likely exist in a monomeric state or at least as fleeting and small aggregates. This situation is reflected in the crystal packing (Figure 4 ) of the 8 2þ dications wherein longrange, repetitive π 3 3 3 π associations between diazaperopyrenium cores are impeded. These salts may be better suited to transitioning across membrane barriers or intercalating more efficiently than the aggregated species, leading to a marked increase in cell growth inhibition, as demonstrated by the higher potency of 8 3 2Cl relative to the other DAPP 2þ salts tested. Dynamic light scattering (DLS) experiments were conducted on 1 3 2Cl, 3 3 2Cl, 5 3 2Cl and 8 3 2Cl to determine if the different DAPP 2þ salts undergo solventdirected aggregation in solution (see Supporting Information). In aqueous solution, 8 3 2Cl was observed to form small (50À100 nm) stable aggregates, while 1 3 2Cl and 3 3 2Cl were observed to form only large There is evidence, however, to support the belief that the dicationic state of 8 2þ also plays a significant role in determining the potency and pharmacokinetic behavior observed during the screening against cancer cells.
RESULTS AND DISCUSSION
In support of this possibility we prepared compound 9 ( Figure 6) , namely, N,N-bis(2,6-diisopropylphenyl) perylene-3,4:9,10-bis(dicarboximide), which was also screened against cancer cell lines. Although location of bulky substituents on the terminal nitrogens could prevent aggregation, the presence of the carboximides removes the possibility of the formation of dications. This constitution allowed us to observe the effect of charge on the chemotherapeutic potency, while still maintaining some of the general structural ingredients of 8 2þ . It transpires that the two 2,6-iPr 2 C 6 H 3 groups in 9 enhance its solubility in Me 2 SO, by comparison with other perylene diimides with less bulky substituents. Of the 10 cell lines screened, all but one showed cell viability greater than 80%, suggesting that 9 is not as effective a potential chemotherapeutic drug target as 8 3 2Cl. Compound 9 displayed (Table 3) , most likely plays a crucial role in determining the effectiveness of these polyaromatic compounds as chemotherapeutic agents. The charged state could contribute to both the strengthening of the DNA intercalating ability of the DAPP 2þ dications as well as to increasing the probability of transition of the drug from the lipophilic membrane into the hydrophilic cytosol or nucleus. However, as we observed with HL-60, where 9 is more cytotoxic than 8 3 2Cl, there appears to be no universal characteristic associated with these compounds that suggests treatment of all cancer cell lines. In order to investigate the nature of the structural effects of the DAPP 2þ dications in more detail, the degrees of aromaticity in the case of two of the dications were altered. In many drugs, the presence 59 of a basic amino group changes their solublities and pharmacodynamics properties, as well as providing some degree of lysosomotropic ability. 60À62 The library of structures examined so far in this investigation has focused on a possible correlation between π 3 3 3 π stacking propensity and therapeutic activity. Since failing to oxidize the "deoxygenated perylene diimide" intermediate at the final stage in synthesis leaves us with a protonatable amine derivative, it was of interest to test the therapeutic behavior of the basic amine as well as the change in the aromaticity in these compounds on cell viability. A 3 2Cl and B 3 2Cl, derivatives of 3 3 2Cl and 5 3 2Cl, respectively, were obtained as a result of not exposing the "deoxygenated perylene diimide" intermediate to the final oxidative dehydrogenation conditions, and thus the terminal heterocyclic rings are no longer aromatic in these structures ( Figure 6 ). Although a comparison of cell viability between the diazaperopyrenium and hexahydroanthradiisoquinoline aromatic salts revealed similar cytotoxicities for most of the cell lines tested, A 3 2Cl (Figure 7 , Table 3 ) 
METHODS
Crystal Growth. Single crystals of suitable quality for single crystal X-ray diffraction were grown by the diffusion of iPr 2 O vapor into MeCN solutions of 3 3 2PF 6 , 6 3 2PF 6 , and 7 3 2PF 6 . Likewise, good quality single crystals of 5 3 2PF 6 and 8 3 Cell Studies. For cell studies, the hexafluorophosphate counterions were changed to chlorides by the addition of n-butyl ammonium chloride to acetonitrile solutions of the bis-(hexafluorophosphate)s. The resulting precipitate (the dichloride salt) was then collected and washed with acetonitrile to remove any excess of n-butyl ammonium chloride. The dichloride salts were then solubilized in a Me 2 SO/H 2 O mixture (50:50) to afford either 4 mM (1 3 2Cl, 3 3 2Cl, 6 3 2Cl, 7 3 2Cl and A 3 2Cl) or 8 mM (compounds 2 3 2Cl, 4 3 2Cl, 5 3 2Cl, 8 3 2Cl and B 3 2Cl) solutions, which were subsequently used for cell viability studies. Compound 9 was solubilized in Me 2 SO to produce an 8 mM solution that was used for cell viability studies. The growth inhibition of various cell lines was determined according to the protocols from the NCI/NIH Developmental Therapeutics Program, and in collaboration with the Northwestern University Developmental Therapeutics Core Facility. Cells were plated in triplicate in 96 well plates. The cells were plated at densities of 40 000 per well in 100 μL for suspended cells (Jurkat and HL-60) and 20 000 per well in 100 μL for adherent cells (HT-29, HT-1080, PC3, MDA-MB-231, FaDu, HepG2, Hela, SKMEL-2). The cells were grown in RPMI 1640 medium containing 5% fetal bovine serum and 2 mM L-glutamine. Following cell inoculation, the plates were incubated at 37°C, 5% CO 2 , 95% air and 100% relative humidity for 24 h.
After 24 h, the time-zero cells were fixed with ice cold trichloroacetic acid (TCA) (80% for suspended cells and 50% for adherent cells) and washed five times with water. 
ARTICLE
The compounds to be tested were diluted to twice the desired test concentration in complete media containing 50 μg/mL gentamicin. Aliquots of the compounds were added to the cells in a 1:1 volume ratio and the plates were incubated for an additional 48 h. The cells were then fixed using ice-cold trichloroacetic acid (TCA) (80% for suspended cells and 50% for adherent cells) and washed five times with water. For the cell growth inhibition studies, the cells were stained by adding 100 μL of Sulphorhodamine B (SRB) solution (0.4% in 1% acetic acid) to each well, followed by incubation for 10 min at room temperature. The unbound dye was removed with five washes with 1% acetic acid, following which the plates were allowed to air-dry. The bound stain was solubilized for absorbance reading by adding 100 μL of 10 mM trizma (2-amino-2-(hydroxymethyl)-1,3-propanediol) base solution to each well, followed by absorbance reading at 490 nm with an automated plate reader (Synergy H1-M Microplate reader). The cell viability data reported was normalized to cell viability in an H 2 O/DMSO 50:50 mixture unless otherwise stated. For half maximal inhibitory concentration studies, after fixing 100 μM Cell Titer Glo (Promega) was added to each well for 30 min. The wells were shaken for 2 min, followed by absorbance measurements.
Dynamic Light Scattering. The DAPP 2þ salts were dissolved in H 2 O/Me 2 SO (1:1, v/v, 500 μL) to imitate the conditions used to introduce the sample to the cell cultures. Either deionized H 2 O (1.0 mL), pH 7.2 phosphate buffered solution (1.0 mL) or the RPMI 1640 medium containing 5% fetal bovine serum and 2 mM L-glutamine (1.0 mL) was added to a Disposable Solvent Resistant Micro Cuvette (ZEN0040, Malvern). The DAPP 2þ salt solution (10 μL) was then injected into the cuvette. Analyses of the samples were carried out on a Malvern Instruments Inc., Zetasizer Nano ZS. Measurements were taken using a standard operating procedure (SOP) (10 scans at 10 s/scan) for aqueous solutions at 25°C. All solvents were run as blanks to identify peaks that correlate to the protein additives or possible impurities in solution.
